At 19 June 2018 the Innovative Medicines Initiative
To read: The Future of Patient Data Report
IMI is celebrating its 10th anniversary. We are proud to be
Real-world data (RWD) is health-related data derived from
Big Data has been attributed as having “transformative ...
Read the IMI interview with HARMONY Partners Jan
@HARMONY Talks: Partners, Work Package Leaders and Leaders
@HARMONY Talks: Partners, Work Package Leaders and Leaders
HARMONY presented at the Fifth Annual Life Science R&D Data
EU’s Health Commissioner Andriukaitis: Big data has ‘enormous’ ...
HARMONY in the new open access journal of the European Hematology ...
Advancing a field by building consortia: The example of the
We are looking forward to another exciting and productive
Wishing you a Healthy and Prosperous 2018!
What is a health outcome? View and listen to the ICHOM video. ...
HARMONY Networking at ASH2017, the 59th Annual Meeting and Exposition ...
Connecting at the 1st European Alliance for Personalised Medicine ...
Making Change Happen in Health: Harnessing the Benefits of Science ...
HARMONY
Healthcare Alliance for Resourceful Medicine Offensive against Neoplasms in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).